Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa

被引:51
作者
Ariyoshi, K
Jaffar, S
Alabi, AS
Berry, N
van der Loeff, MS
Sabally, S
N'Gom, PT
Corrah, T
Tedder, R
Whittle, H
机构
[1] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo 2080011, Japan
[2] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England
[3] UCL Royal Free & Univ Coll Med Sch, Dept Virol, London, England
关键词
HIV-2; viral load; CD4; progression; prognosis;
D O I
10.1097/00002030-200003100-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To examine whether the levels of plasma RNA and DNA provirus predict the rate of CD4 cell decline and patient death. Design: Retrospective analysis of HIV-2 cohort subjects. Methods: Fifty-two subjects were recruited between January 1991 and December 1992. HIV-2 RNA levels in plasma and DNA levels in peripheral blood mononuclear cells (PBMC) were measured using in-house quantitative PCR assays. The annual rate of CD4 cell decline was calculated using the least-squares method. The survival data on 31 December 1997 were used. Results: The mean percentage of CD4 cells at baseline was 30.7 (SD, 9.5). In a linear regression model, the annual rate of CD I cell decline was 1.76 CD4% faster for every increase in one log(10) RNA copies/ml [95% confidence interval (CI), 0.81-2.7; P = 0.0006; r = 0.46; n = 52] and 1.76 CD4% faster for every increase in log(10) DNA copies/10(5) PBMC (95% CI 0.46-3,1; P = 0.01; r = 0.33; n = 42). In a multiple linear regression model, RNA load was related to CD4 decline independently of DNA load (P = 0.02). The overall mortality rate was 7.29/100 person-years. In a Cox regression model, the hazard rate increased by 2.12 for each log(10) increase in RNA load (95% CI, 1.3-3.5; P = 0.0023) but only by 1.09 for each log(10) increase in DNA load (95% CI, 0.64-1.87; P = 0.8). Conclusion: This longitudinal study shows for the first time that a baseline HIV-2 RNA load predicts the rate of disease progression. HIV-2-infected patients with a high viral load may need to be treated as vigorously as HIV-1 patients. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:339 / 344
页数:6
相关论文
共 39 条
[1]   REPLICATIVE CAPACITY OF HIV-2, LIKE HIV-1, CORRELATES WITH SEVERITY OF IMMUNODEFICIENCY [J].
ALBERT, J ;
NAUCLER, A ;
BOTTIGER, B ;
BROLIDEN, PA ;
ALBINO, P ;
OUATTARA, SA ;
BJORKEGREN, C ;
VALENTIN, A ;
BIBERFELD, G ;
FENYO, EM .
AIDS, 1990, 4 (04) :291-295
[2]   HIV-2-SPECIFIC CYTOTOXIC T-LYMPHOCYTE ACTIVITY IS INVERSELY RELATED TO PROVIRAL LOAD [J].
ARIYOSHI, K ;
CHAM, F ;
BERRY, N ;
JAFFAR, S ;
SABALLY, S ;
CORRAH, T ;
WHITTLE, H .
AIDS, 1995, 9 (06) :555-559
[3]   A community-based study of human immunodeficiency virus type 2 provirus load in a rural village in West Africa [J].
Ariyoshi, K ;
Berry, N ;
Wilkins, A ;
Ricard, D ;
Aaby, P ;
Naucler, A ;
Ngom, PT ;
Jobe, O ;
Jaffar, S ;
Dias, F ;
Tedder, RS ;
Whittle, H .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01) :245-248
[4]  
Berry N, 1998, J Hum Virol, V1, P457
[5]   HIV TYPE-2 PROVIRAL LOAD MEASURED BY QUANTITATIVE POLYMERASE CHAIN-REACTION CORRELATES WITH CD4+ LYMPHOPENIA IN HIV TYPE 2-INFECTED INDIVIDUALS [J].
BERRY, N ;
ARIYOSHI, K ;
JOBE, O ;
NGUM, PT ;
CORRAH, T ;
WILKINS, A ;
WHITTLE, H ;
TEDDER, R .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (08) :1031-1037
[6]   AUTOLOGOUS NEUTRALIZING ANTIBODIES PREVAIL IN HIV-2 BUT NOT IN HIV-1 INFECTION [J].
BJORLING, E ;
SCARLATTI, G ;
VONGEGERFELT, A ;
ALBERT, J ;
BIBERFELD, G ;
CHIODI, F ;
NORRBY, E ;
FENYO, EM .
VIROLOGY, 1993, 193 (01) :528-530
[7]   VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
CAO, YZ ;
QIN, LM ;
ZHANG, LQ ;
SAFRIT, J ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :201-208
[8]   HLA and HIV-1:: Heterozygote advantage and B*35-Cw*04 disadvantage [J].
Carrington, M ;
Nelson, GW ;
Martin, MP ;
Kissner, T ;
Vlahov, D ;
Goedert, JJ ;
Kaslow, R ;
Buchbinder, S ;
Hoots, K ;
O'Brien, SJ .
SCIENCE, 1999, 283 (5408) :1748-1752
[9]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 INFECTION ASSOCIATED WITH AIDS IN WEST-AFRICA [J].
CLAVEL, F ;
MANSINHO, K ;
CHAMARET, S ;
GUETARD, D ;
FAVIER, V ;
NINA, J ;
SANTOSFERREIRA, MO ;
CHAMPALIMAUD, JL ;
MONTAGNIER, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (19) :1180-1185
[10]   Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene [J].
Dean, M ;
Carrington, M ;
Winkler, C ;
Huttley, GA ;
Smith, MW ;
Allikmets, R ;
Goedert, JJ ;
Buchbinder, SP ;
Vittinghoff, E ;
Gomperts, E ;
Donfield, S ;
Vlahov, D ;
Kaslow, R ;
Saah, A ;
Rinaldo, C ;
Detels, R ;
OBrien, SJ .
SCIENCE, 1996, 273 (5283) :1856-1862